StockWatch
·
Pharmaceutical Preparations
Corporate ActionMay 21, 2026, 05:02 PM

Azitra Registers 255.7M Shares for Resale; Warns of Dilution

AI Summary

Azitra, Inc. filed an S-1 registration statement for the resale of up to 255,699,381 shares of common stock by selling stockholders. These shares originate from a private placement that closed on March 20, 2026, involving Series A Preferred Stock and Series B and C Warrants. The company will not receive proceeds from the resale, but could receive approximately $21 million if all warrants are exercised for cash. The filing highlights substantial dilution for existing stockholders and a going concern warning from its independent registered public accounting firm.

Key Highlights

  • Up to 255,699,381 shares of common stock registered for resale by selling stockholders.
  • Shares include 85,223,129 Conversion Shares and 170,450,252 Warrant Shares from a private placement.
  • The private placement closed on March 20, 2026, involving Series A Preferred Stock and Series B/C Warrants.
  • Azitra will not receive any proceeds from the sale of shares by the selling stockholders.
  • The company could receive approximately $21 million if all warrants are exercised for cash.
  • The registered shares represent approximately 526% of the 16,192,438 common shares outstanding as of May 19, 2026.
  • Independent auditor's report for 2025 indicates substantial doubt about Azitra's ability to continue as a going concern.
  • Azitra's common stock last traded at $0.19 per share on the NYSE American on May 19, 2026.